Quanterix Announces Landmark Nature Study Redefining Alzheimer’S Disease Neuropathology Prevalence

Reuters
2025.12.22 12:45
Dec 22 (Reuters) - Quanterix Corp (QTRX.O) : * QUANTERIX ANNOUNCES LANDMARK NATURE STUDY REDEFINING ALZHEIMER’S DISEASE NEUROPATHOLOGY PREVALENCE Source text: Further company coverage: (QTRX.O)